247 related articles for article (PubMed ID: 28790135)
1. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
[TBL] [Abstract][Full Text] [Related]
2. SREBP1c-CRY1 signalling represses hepatic glucose production by promoting FOXO1 degradation during refeeding.
Jang H; Lee GY; Selby CP; Lee G; Jeon YG; Lee JH; Cheng KK; Titchenell P; Birnbaum MJ; Xu A; Sancar A; Kim JB
Nat Commun; 2016 Jul; 7():12180. PubMed ID: 27412556
[TBL] [Abstract][Full Text] [Related]
3. Hepatic GSK3β-Dependent CRY1 Degradation Contributes to Diabetic Hyperglycemia.
Kim YY; Jang H; Lee G; Jeon YG; Sohn JH; Han JS; Lee WT; Park J; Huh JY; Nahmgoong H; Han SM; Kim J; Pak M; Kim S; Kim JS; Kim JB
Diabetes; 2022 Jul; 71(7):1373-1387. PubMed ID: 35476750
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
Goyal N; Tiwary S; Kesharwani D; Datta M
J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
[TBL] [Abstract][Full Text] [Related]
5. CUL4-DDB1-CDT2 E3 Ligase Regulates the Molecular Clock Activity by Promoting Ubiquitination-Dependent Degradation of the Mammalian CRY1.
Tong X; Zhang D; Guha A; Arthurs B; Cazares V; Gupta N; Yin L
PLoS One; 2015; 10(10):e0139725. PubMed ID: 26431207
[TBL] [Abstract][Full Text] [Related]
6. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
[TBL] [Abstract][Full Text] [Related]
7. SCP4 Promotes Gluconeogenesis Through FoxO1/3a Dephosphorylation.
Cao J; Yu Y; Zhang Z; Chen X; Hu Z; Tong Q; Chang J; Feng XH; Lin X
Diabetes; 2018 Jan; 67(1):46-57. PubMed ID: 28851713
[TBL] [Abstract][Full Text] [Related]
8. DDB1 E3 ligase controls dietary fructose-induced ChREBPα stabilization and liver steatosis via CRY1.
Tong X; Zhang D; Shabandri O; Oh J; Jin E; Stamper K; Yang M; Zhao Z; Yin L
Metabolism; 2020 Jun; 107():154222. PubMed ID: 32246987
[TBL] [Abstract][Full Text] [Related]
9. Autophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1.
Toledo M; Batista-Gonzalez A; Merheb E; Aoun ML; Tarabra E; Feng D; Sarparanta J; Merlo P; Botrè F; Schwartz GJ; Pessin JE; Singh R
Cell Metab; 2018 Aug; 28(2):268-281.e4. PubMed ID: 29937374
[TBL] [Abstract][Full Text] [Related]
10. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
12. Spexin alleviates insulin resistance and inhibits hepatic gluconeogenesis via the FoxO1/PGC-1α pathway in high-fat-diet-induced rats and insulin resistant cells.
Gu L; Ding X; Wang Y; Gu M; Zhang J; Yan S; Li N; Song Z; Yin J; Lu L; Peng Y
Int J Biol Sci; 2019; 15(13):2815-2829. PubMed ID: 31853220
[No Abstract] [Full Text] [Related]
13. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin F
Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
[TBL] [Abstract][Full Text] [Related]
15. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
[TBL] [Abstract][Full Text] [Related]
16. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
[TBL] [Abstract][Full Text] [Related]
17. Heme Oxygenase-1 Regulates Ferrous Iron and Foxo1 in Control of Hepatic Gluconeogenesis.
Liao W; Yang W; Shen Z; Ai W; Pan Q; Sun Y; Guo S
Diabetes; 2021 Mar; 70(3):696-709. PubMed ID: 33408127
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-721 regulates gluconeogenesis via KDM2A-mediated epigenetic modulation in diet-induced insulin resistance in C57BL/6J mice.
Kabeer SW; Sharma S; Sriramdasu S; Tikoo K
Biol Res; 2024 May; 57(1):27. PubMed ID: 38745315
[TBL] [Abstract][Full Text] [Related]
19. Cystathionine γ-lyase deficiency aggravates obesity-related insulin resistance via FoxO1-dependent hepatic gluconeogenesis.
Guo W; Li D; You Y; Li W; Hu B; Zhang S; Miao L; Xian M; Zhu Y; Shen X
FASEB J; 2019 Mar; 33(3):4212-4224. PubMed ID: 30526049
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
